Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2010-05-04

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.09m05911bluPMID 20492845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

  2010cited by this paper
• Anxiety Symptom Severity and Functional Recovery Or Relapse

  2009cited by this paper
• Quality of life and functional impairment in obsessive–compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls

  2009cited by this paper
• Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder

  2008cited by this paper
• Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder.

  2008cited by this paper
• Quality of life in obsessive‐compulsive disorder: an evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment

  2008cited by this paper
• Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder.

  2007cited by this paper
• Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

  2007cited by this paper
• Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial

  2007cited by this paper
• Escitalopram prevents relapse of obsessive-compulsive disorder.

  2007cited by this paper
• Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

  2006cited by this paper
• Impact of obsessive-compulsive disorder on quality of life.

  2006cited by this paper
• Job performance deficits due to depression.

  2006cited by this paper
• Standard criteria for relapse are needed in obsessive–compulsive disorder

  2005cited by this paper
• Evidence-based pharmacotherapy of obsessive-compulsive disorder.

  2005cited by this paper
• Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

  2005cited by this paper
• Quality of life in obsessive-compulsive disorder before and after treatment.

  2005cited by this paper
• Quality of Life in Anxiety Disorders: A Comparison of Obsessive-Compulsive Disorder, Social Anxiety Disorder, and Panic Disorder

  2003cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.

  2003cited by this paper
• A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.

  2003cited by this paper
• Effect of a pharmacological intervention on quality of life in patients with obsessive–compulsive disorder

  2003cited by this paper
• Treatment non-response in OCD: methodological issues and operational definitions.

  2002cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

  2002cited by this paper
• Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

  2001cited by this paper
• Quality of life and disability in patients with obsessive-compulsive disorder

  2001cited by this paper
• Social functioning and quality of life comparisons between obsessive–compulsive and schizophrenic disorders

  2001cited by this paper
• Quality of life in obsessive-compulsive disorder.

  2000cited by this paper
• Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program.

  1999cited by this paper
• Evidence-Based Pharmacotherapy for Obsessive-Compulsive Disorder

  1999cited by this paper
• The measurement of disability.

  1996cited by this paper
• Quality of life for patients with obsessive-compulsive disorder.

  1996cited by this paper
• The measurement of disability

  1996cited by this paper
• Obsessive-compulsive and spectrum disorders: overview and quality of life issues.

  1996cited by this paper
• The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group.

  1994cited by this paper
• SF-36 physical and mental health summary scales : a user's manual

  1994cited by this paper
• One‐month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study

  1993cited by this paper
• Treatments of depression and the functional capacity to work.

  1992cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• The MOS 36-Item Short-Form Health Survey (SF-36)

  1992cited by this paper
• The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

  1989cited by this paper
• The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

  1989cited by this paper
• The epidemiology of obsessive-compulsive disorder in five US communities.

  1988cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper

• Habit as a therapeutic component in psychological treatment for obsessive-compulsive disorder: A randomised controlled feasibility study.

  2026cites this paper
• Meta-analysis of age at help-seeking and duration of untreated illness (DUI) in obsessive-compulsive disorder (OCD): The need for early interventions.

  2025cites this paper
• High Intensity Approaches to Exposure and Response Prevention for Obsessive-Compulsive Disorder.

  2025cites this paper
• Beyond symptom reduction: targeting cognitive deficits in obsessive-compulsive disorder treatment.

  2025cites this paper
• Stress events, phenotypes, and duration of untreated illness in obsessive-compulsive disorder.

  2025cites this paper
• Echoes of ease: Tracing the course of obsessive‐compulsive symptoms in the aftermath of a pandemic—Insights from a four‐year panel study

  2025cites this paper
• Beyond symptom improvement: transdiagnostic and disorder‐specific ways to assess functional and quality of life outcomes across mental disorders in adults

  2025influential citation
• Peripheral Blood Biomarkers Reveal Dysregulated Monoaminergic Pathways in Obsessive–Compulsive Disorder: A Transcriptional and Epigenetic Analysis

  2025cites this paper
• Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.

  2025cites this paper
• Inhibition of TRPM3 channels in the medial prefrontal cortex mitigates OCD symptoms following traumatic brain injury

  2025cites this paper
• Exploring Genetic and Epigenetic Markers for Predicting or Monitoring Response to Cognitive-Behavioral Therapy in Obsessive-Compulsive Disorder: A Systematic Review.

  2025cites this paper
• Obsessive-compulsive symptoms and traits in patients with burning mouth syndrome: a cross-sectional multicentric analysis

  2025cites this paper
• Prevalence and associated factors of obsessive compulsive symptoms among under graduate medical and health science students in Dilla university, Ethiopia: a cross-sectional study

  2025cites this paper
• Defining treatment response in gambling disorder.

  2024cites this paper
• Early-onset obsessive-compulsive disorder: Sociodemographic and clinical characterization of a large outpatient cohort.

  2024cites this paper
• Altered dynamic neural activities in individuals with obsessive-compulsive disorder and comorbid depressive symptoms

  2024cites this paper
• Effectiveness of a tertiary specialist obsessive–compulsive disorder (OCD) service in improving clinical outcomes for patients with treatment-resistant/complex OCD

  2024cites this paper
• Does nonacceptance of emotions and the fear of guilt influence the association between trait guilt and obsessive-compulsive symptoms? A moderation analysis in a non-clinical sample

  2024cites this paper
• Obsessive‐compulsive disorder and men's health. Part 2: Treatment and related sexual dysfunction

  2023cites this paper
• Prevalence of Obsessive-Compulsive Disorder Among Psychology Students

  2023cites this paper
• Things that make you go Hmm: Myths and misconceptions within cognitive-behavioral treatment of obsessive-compulsive disorder.

  2023cites this paper
• A pilot study of fMRI targeted rTMS for obsessive compulsive disorder.

  2022cites this paper
• Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1).

  2022cites this paper
• the article: “ Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial

  2022cites this paper
• Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder.

  2022cites this paper
• Generation and characterization of iPSCs from a patient with obsessive-compulsive disorder, his mother with schizophrenia and his healthy father.

  2022cites this paper
• Treatment-resistant OCD: Pharmacotherapies in adults.

  2022cites this paper
• Shape analysis of subcortical structures in obsessive‐compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta‐analysis by the OCD Brain Imaging Consortium

  2022cites this paper
• The global assessment of OCD.

  2022cites this paper
• First vs second wave of COVID-19 pandemic in patients with obsessive compulsive disorder: A multicentre report from tertiary clinics in Northern Italy

  2022cites this paper
• Paroxetine Increases δ Opioid Responsiveness in Sensory Neurons

  2022influential citation
• Cortical thickness and surface area in patients with obsessive compulsive disorder and their unaffected siblings

  2022influential citation
• Cognitive–Behavioral Treatment of Obsessive–Compulsive Disorder: The Results of a Naturalistic Outcomes Study

  2022cites this paper
• A meta-analysis of the effects of non-invasive brain stimulation on obsessive-compulsive disorder.

  2022cites this paper
• Knowledge and competency standards for specialized cognitive behavior therapy for adult obsessive-compulsive disorder.

  2021cites this paper
• Obsessive-compulsive symptoms and the Covid-19 pandemic: A rapid scoping review

  2021cites this paper
• Intervention Cost-Effectiveness for Pediatric Anxiety and OCD: A Systematic Review and Integrated Database Model.

  2021cites this paper
• Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials.

  2021cites this paper
• The Future of Obsessive-Compulsive Spectrum Disorders: A Research Perspective.

  2021cites this paper
• Functional interventions as augmentation strategies for obsessive-compulsive disorder (OCD): scoping review and expert survey from the international college of obsessive-compulsive spectrum disorders (ICOCS)

  2021cites this paper
• Introduction to knowledge and competency standards for specialized treatments for obsessive-compulsive disorder throughout the lifespan: Phase two series by the International Accreditation Task Force of the Canadian Institute for Obsessive Compulsive Disorders (CIOCD, www.ciocd.ca).

  2021cites this paper
• Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

  2020cites this paper
• P.710 Functional interventions as augmentation strategies for obsessive-compulsive disorder: scoping review and expert survey from International College of Obsessive-Compulsive Spectrum Disorders

  2020cites this paper
• On Obsessions: A Phenomenology of Doubt, Images, and the Obsessive-Compulsive Chronological Structure in Obsessive-Compulsive Disorder

  2020cites this paper
• Brain micro-architecture and disinhibition: a latent phenotyping study across 33 impulsive and compulsive behaviours

  2020cites this paper
• Treating refractory obsessive–compulsive disorder with transcranial direct current stimulation: An open label study

  2020cites this paper
• What Happened to Patients With Obsessive Compulsive Disorder During the COVID-19 Pandemic? A Multicentre Report From Tertiary Clinics in Northern Italy

  2020cites this paper
• Pharmacological Treatments for Obsessive-Compulsive and Related Disorders: A Transdiagnostic Perspective

  2019cites this paper
• MR-Guided Focused Ultrasound Versus Radiofrequency Capsulotomy for Treatment-Refractory Obsessive-Compulsive Disorder: A Cost-Effectiveness Threshold Analysis

  2019cites this paper
• Early intervention for obsessive compulsive disorder: An expert consensus statement.

  2019cites this paper
• Pharmacokinetics of serotonergic drugs: focus on OCD

  2019cites this paper
• Quality of life in children and adolescents with obsessive-compulsive disorder: The Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q).

  2019cites this paper
• Four-year course of quality of life and obsessive–compulsive disorder

  2019cites this paper
• Patients with OCD report lower quality of life after controlling for expert-rated symptoms of depression and anxiety.

  2018cites this paper
• Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder

  2018cites this paper
• Cortical thickness and white matter integrity abnormalities in obsessive–compulsive disorder: A combined multimodal surface‐based morphometry and tract‐based spatial statistics study

  2018cites this paper
• Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial

  2017cites this paper
• Quality of life in children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis

  2017cites this paper
• Drop-out and efficacy of group versus individual cognitive behavioural therapy: What works best for Obsessive-Compulsive Disorder? A systematic review and meta-analysis of direct comparisons.

  2017cites this paper
• Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder

  2017cites this paper
• The effect of treatment on quality of life and functioning in OCD.

  2017cites this paper
• Cortical thickness in obsessive–compulsive disorder: Multisite mega-analysis of 780 brain scans from six centres

  2017cites this paper
• Determining face, predictive, construct validity and novel receptor targets in a spontaneous compulsive-like mouse model

  2017cites this paper
• Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive–Compulsive Disorder in Childhood

  2017cites this paper
• Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive–compulsive disorder

  2017cites this paper
• Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.

  2017cites this paper
• Relapse Prevention and the Need for Ongoing Pharmacological Treatment in Body Dysmorphic Disorder.

  2016cites this paper
• Treatment-Resistant Obsessive-Compulsive Disorder (OCD): Focus on Antipsychotic Augmentation to SRIs

  2016cites this paper
• Treatment-Resistant Obsessive-Compulsive Disorder (OCD): Focus on Antipsychotic Augmentation to SRIs

  2016cites this paper
• Unmet needs of the patients with obsessive-compulsive disorder.

  2016cites this paper
• Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.

  2016cites this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.

  2016cites this paper
• Adult obsessive-compulsive disorder and quality of life outcomes: A systematic review and meta-analysis.

  2016cites this paper
• Anxiety symptoms and functional impairment: A systematic review of the correlation between the two measures.

  2016cites this paper
• Quality of life and relationship satisfaction of patients with Obsessive Compulsive Disorder.

  2016cites this paper
• The relation between depressive and obsessive-compulsive symptoms in obsessive-compulsive disorder: Results from a large, naturalistic follow-up study.

  2016cites this paper
• Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive–Compulsive Disorder in Childhood

  2016cites this paper
• The cost and impact of compulsivity: A research perspective.

  2016cites this paper
• Obsessive compulsive and related disorders: comparing DSM-5 and ICD-11

  2016cites this paper
• Specialized psychological and pharmacological treatments for obsessive-compulsive disorder throughout the lifespan: a special series by the Accreditation Task Force (ATF) of The Canadian Institute for Obsessive Compulsive Disorders (CIOCD, www.ciocd.ca).

  2015cites this paper
• Quality of life in children with OCD before and after treatment

  2015influential citation
• Brain Connectivity and Prediction of Relapse after Cognitive-Behavioral Therapy in Obsessive–Compulsive Disorder

  2015cites this paper
• Generalized and specific emotion impairments as potential markers of severity in Obsessive-Compulsive Disorder: a preliminary study using Facial Action Coding System (FACS).

  2015cites this paper
• Dynamics of the Life Quality Parameters in HIV-Positive Patients With Opiate Dependence

  2015cites this paper
• Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.

  2015cites this paper
• The Affect Of Religious Cognitive-Behavior Therapy On Quality Of Life Obsessive –Compulsive Disorder

  2015cites this paper
• Obsessive-Compulsive Disorder and quality of life outcomes: protocol for a systematic review and meta-analysis of cross-sectional case-control studies

  2015cites this paper
• Management of Obsessive-Compulsive Disorder

  2014cites this paper
• Obsessive compulsive symptoms are related to lower quality of life in patients with Schizophrenia

  2014cites this paper
• Patient-reported outcomes in obsessive-compulsive disorder

  2014cites this paper
• Comorbidity: Social Anxiety Disorder and Psychiatric Comorbidity are not Shy to Co‐Occur

  2014cites this paper
• Quality of life in children with OCD with and without comorbidity

  2014cites this paper
• Treatment-Resistant Obsessive-Compulsive Disorder (OCD): Focus on Antipsychotic Augmentation to SRIs

  2014cites this paper
• Calidad de Vida en Pacientes con Trastorno Obsesivo Compulsivo: Una revisión

  2013cites this paper
• TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER ( OCD ) : CURRENT KNOWLEDGE AND OPEN QUESTIONS

  2013cites this paper
• Evidence-based treatment pathways for translational studies in obsessive-compulsive disorders.

  2013cites this paper
• Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond

  2013cites this paper
• Quality of life in obsessive compulsive disorder

  2013cites this paper
• Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms

  2013cites this paper
• Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up

  2013influential citation